251 related articles for article (PubMed ID: 25172140)
1. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.
Ramírez-Venegas A; Sansores RH; Quintana-Carrillo RH; Velázquez-Uncal M; Hernandez-Zenteno RJ; Sánchez-Romero C; Velazquez-Montero A; Flores-Trujillo F
Am J Respir Crit Care Med; 2014 Nov; 190(9):996-1002. PubMed ID: 25172140
[TBL] [Abstract][Full Text] [Related]
2. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.
Golpe R; Sanjuán López P; Cano Jiménez E; Castro Añón O; Pérez de Llano LA
Arch Bronconeumol; 2014 Aug; 50(8):318-24. PubMed ID: 24576449
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.
Olloquequi J; Jaime S; Parra V; Cornejo-Córdova E; Valdivia G; Agustí À; Silva O R
Respir Res; 2018 Jan; 19(1):13. PubMed ID: 29347936
[TBL] [Abstract][Full Text] [Related]
4. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
5. Smoke, Biomass Exposure, and COPD Risk in the Primary Care Setting: The PUMA Study.
Montes de Oca M; Zabert G; Moreno D; Laucho-Contreras ME; Lopez Varela MV; Surmont F
Respir Care; 2017 Aug; 62(8):1058-1066. PubMed ID: 28559464
[TBL] [Abstract][Full Text] [Related]
6. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
[TBL] [Abstract][Full Text] [Related]
7. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.
Nishimura M; Makita H; Nagai K; Konno S; Nasuhara Y; Hasegawa M; Shimizu K; Betsuyaku T; Ito YM; Fuke S; Igarashi T; Akiyama Y; Ogura S;
Am J Respir Crit Care Med; 2012 Jan; 185(1):44-52. PubMed ID: 22016444
[TBL] [Abstract][Full Text] [Related]
8. COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women.
Camp PG; Ramirez-Venegas A; Sansores RH; Alva LF; McDougall JE; Sin DD; Paré PD; Müller NL; Silva CI; Rojas CE; Coxson HO
Eur Respir J; 2014 Mar; 43(3):725-34. PubMed ID: 24114962
[TBL] [Abstract][Full Text] [Related]
9. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
Lange P; Celli B; Agustí A; Boje Jensen G; Divo M; Faner R; Guerra S; Marott JL; Martinez FD; Martinez-Camblor P; Meek P; Owen CA; Petersen H; Pinto-Plata V; Schnohr P; Sood A; Soriano JB; Tesfaigzi Y; Vestbo J
N Engl J Med; 2015 Jul; 373(2):111-22. PubMed ID: 26154786
[TBL] [Abstract][Full Text] [Related]
10. Chronic obstructive pulmonary disease in women exposed to wood stove smoke.
Moreira MA; Barbosa MA; Jardim JR; Queiroz MC; Inácio LU
Rev Assoc Med Bras (1992); 2013; 59(6):607-13. PubMed ID: 24211014
[TBL] [Abstract][Full Text] [Related]
11. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
Wise RA
Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
[TBL] [Abstract][Full Text] [Related]
12. Decline in FEV1 related to genetic polymorphisms (+138insA/delA and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study.
Kaparianos A; Argyropoulou E; Efremidis G; Flordellis C; Spiropoulos K
Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):705-19. PubMed ID: 20707291
[TBL] [Abstract][Full Text] [Related]
13. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass.
Ceylan E; Kocyigit A; Gencer M; Aksoy N; Selek S
Respir Med; 2006 Jul; 100(7):1270-6. PubMed ID: 16307872
[TBL] [Abstract][Full Text] [Related]
14. Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease.
Harber P; Tashkin DP; Simmons M; Crawford L; Hnizdo E; Connett J;
Am J Respir Crit Care Med; 2007 Nov; 176(10):994-1000. PubMed ID: 17626912
[TBL] [Abstract][Full Text] [Related]
15. Analysis of FEV1 decline in relatively healthy heavy smokers: implications of expressing changes in FEV1 in relative terms.
Thomsen LH; Dirksen A; Shaker SB; Skovgaard LT; Dahlbäck M; Pedersen JH
COPD; 2014 Feb; 11(1):96-104. PubMed ID: 24111638
[TBL] [Abstract][Full Text] [Related]
16. Putative Systemic Biomarkers of Biomass Smoke-Induced Chronic Obstructive Pulmonary Disease among Women in a Rural South Indian Population.
Vishweswaraiah S; Thimraj TA; George L; Krishnarao CS; Lokesh KS; Siddaiah JB; Larsson K; Upadhyay S; Palmberg L; Anand MP; Ganguly K
Dis Markers; 2018; 2018():4949175. PubMed ID: 30595762
[TBL] [Abstract][Full Text] [Related]
17. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
[TBL] [Abstract][Full Text] [Related]
18. Malondialdehyde and superoxide dismutase correlate with FEV(1) in patients with COPD associated with wood smoke exposure and tobacco smoking.
Montaño M; Cisneros J; Ramírez-Venegas A; Pedraza-Chaverri J; Mercado D; Ramos C; Sansores RH
Inhal Toxicol; 2010 Aug; 22(10):868-74. PubMed ID: 20583895
[TBL] [Abstract][Full Text] [Related]
19. Chronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profile.
Solleiro-Villavicencio H; Quintana-Carrillo R; Falfán-Valencia R; Vargas-Rojas MI
Clin Immunol; 2015 Dec; 161(2):150-5. PubMed ID: 26220216
[TBL] [Abstract][Full Text] [Related]
20. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
